PCT LTD Disinfectants Gain B2B Confidence and Recommendations, and Addition of New Distributor

 

LITTLE RIVER, SC -- December 23, 2020 -- InvestorsHub NewsWire -- PCT LTD (OTC Pink: PCTL) today announced that Len-Tex Wallcoverings, a leading manufacturer of contract wallcoverings, providing an extensive range of design options for the hospitality, healthcare, corporate, institutional, and retail markets, recommended PCTL's Hydrolyte® product as an effective disinfectant.

 

Len-Tex has been diligently testing various institutional disinfectants and cleaners on their wallcovering since the onset of the pandemic. The concern with many of the disinfectant products has been the tendency of the cleaners to create a yellowing or discoloration to the wallcovering. After rigorous testing and research ensuring the compliance of the cleaning product with the latest standards, they found Hydrolyte® effectively disinfects while protecting the original appearance and integrity of their products. To read more about the testing on the Len-Tex blog visit this link.

 

Gary Grieco, PCTL's CEO, commented, "We are very happy to be acknowledged as a company delivering effective and product-safe disinfectants. Len-Tex is a wonderful company that has been around for nearly 40 years and we appreciate the lengths they went through for their clients to test out the best products for cleaning and disinfecting on the market."

 

Recently, PCT Corp. brought on a new Level 2 distributor, a distributor who has executed an agreement with the Company to sell and distribute our US EPA registered products and who is currently beginning their product sales roll-out.  The distributor's headquarters is in Florida, but their central operations are in Georgia and they are targeting a very specific, high demand disinfection market. 

 

About PCT Ltd:

PCT LTD ("PCTL") focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting, cleaning and tracking technologies. The company acquires and holds rights to innovative products and technologies, which are commercialized through its wholly-owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp). Currently trading on OTC:PINK, "PCTL" continues to be actively engaged in applying for listing its common stock to the OTC QB market. The Company established entry into its target markets with commercially viable products in the United States and now continues to gain market share in the U.S. and U.K. 

 

ADDITIONAL NEWS AND CORPORATE UPDATES:

PCTL would like to warn its stockholders and potential investors that material corporate information regarding sales, areas of business and other corporate updates will only be made through press releases or filings with the SEC. PCTL does not utilize social media, chatrooms or other online sources to disclose material information.  The public should only rely on official press releases and corporate filings for accurate and up to date information regarding PCTL.

 

Forward-Looking Statements:

This press release contains "forward-looking statements" as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements."

Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: the ability of PCTL to fulfill orders; PCTL's continued  installation of equipment; subsequent installations of PCTL's Annihilyzer Infection Control Systems and other larger-volume equipment; PCTL's ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCTL to execute its business plan; any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements PCTL makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the SEC. PCTL undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. 

 

Gary Grieco, CEO and Chairman, PCT LTD 
+1(843) 390-7900 Office 
www.para-con.com 
www.pctcorphealth.com 
www.survivalyte.com

 

Rich Inza, Investor Relations (RMJ Consulting, LLC)
+1(843) 491-4611
IR@para-con.com

 

Dave Donlin, Investor Relations (The Cervelle Group)

(407) 405-8142

 

 

SOURCE PCT LTD